Since Hh signaling is well-known to play a major role in NSCLC progression, this suggests that the negative effects of NRF2 on this pathway may antagonize tumorigenicity rather than promote it, as suggested by Liu et al. [59,125,126,127,128,129,130,131]. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.